WallStreetZen

NYSE: TMO
Thermo Fisher Scientific Inc Earnings & Revenue

TMO past earnings growth

How has TMO's earnings growth performed historically?
Company
133.73%
Industry
180.8%
Market
103.11%
TMO's earnings have grown slower (34.03% per year) than the US Diagnostics & Research industry average (62.72%)
Performance
TMO's earnings have grown faster (34.03% per year) than the US market average (30.14%)
Performance
TMO's earnings growth is accelerating - its growth over the last year (133.73%) is above its 5-year compound annual rate (34.03%)
Performance

TMO past revenue growth

How has TMO's revenue growth performed historically?
Company
45.73%
Industry
40.51%
Market
45.4%
TMO's revenue has grown slower (16.79% per year) than the US Diagnostics & Research industry average (19.1%)
Performance
TMO's revenue has grown slower (16.79% per year) than the US market average (19.13%)
Performance
TMO's revenue growth is accelerating - its growth over the last year (45.73%) is above its 5-year compound annual rate (16.79%)
Performance

TMO earnings and revenue history

Current Revenue
$38.3B
Current Earnings
$8.6B
Current Profit Margin
22.5%
TMO's has demonstrated consistent long-term earnings growth over the past 10 years (532.56%)
Performance

TMO Return on equity

Current Company
24.9%
Current Industry
36.2%
Current Market
32.9%
TMO's Return on Equity (24.9%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

TMO Return on assets

Current Company
12.9%
Current Industry
8.4%
Current Market
7.7%
TMO is generating higher Return on Assets (12.9%) than the US Diagnostics & Research industry average (8.37%)
Performance

TMO Return on capital employed

Current Company
17.25%
Current Industry
13.2%
TMO has gotten more efficient at generating Return on Capital (17.25%) compared to 3 years ago (6.74%)
Performance

TMO earnings dates

Next earnings date
Oct 19, 2021

Thermo Fisher Scientific Earnings & Revenue FAQ

What were TMO's earnings last quarter?

On Invalid Date, Thermo Fisher Scientific (NYSE: TMO) reported Q2 2021 earnings per share (EPS) of $4.65, up 59.25% year over year. Total Thermo Fisher Scientific earnings for the quarter were $1.83 billion. In the same quarter last year, Thermo Fisher Scientific's earnings per share (EPS) was $2.92.

What was TMO's earnings growth in the past year?

As of Q3 2021, Thermo Fisher Scientific's earnings has grown 133.73% year over year. This is 47.07 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 180.8%. Thermo Fisher Scientific's earnings in the past year totalled $8.60 billion.

What is TMO's earnings date?

Thermo Fisher Scientific's earnings date is Invalid Date. Add TMO to your watchlist to be reminded of TMO's next earnings announcement.

What was TMO's revenue last quarter?

On Invalid Date, Thermo Fisher Scientific (NYSE: TMO) reported Q2 2021 revenue of $9.27 billion up 34.06% year over year. In the same quarter last year, Thermo Fisher Scientific's revenue was $6.92 billion.

What was TMO's revenue growth in the past year?

As of Q3 2021, Thermo Fisher Scientific's revenue has grown 45.73% year over year. This is 5.22 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 40.51%. Thermo Fisher Scientific's revenue in the past year totalled $38.25 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.